Bruker (NASDAQ:BRKR) is scheduled to be issuing its quarterly earnings data after the market closes on Thursday, February 8th. Analysts expect the company to announce earnings of $0.48 per share for the quarter.
Bruker (NASDAQ:BRKR) opened at $33.44 on Tuesday. The company has a debt-to-equity ratio of 0.65, a current ratio of 2.60 and a quick ratio of 1.60. The company has a market capitalization of $5,200.00, a P/E ratio of 35.57, a price-to-earnings-growth ratio of 2.61 and a beta of 1.05. Bruker has a 12 month low of $21.83 and a 12 month high of $36.53.
BRKR has been the topic of a number of analyst reports. Evercore ISI initiated coverage on Bruker in a research note on Wednesday, January 3rd. They issued an “in-line” rating and a $36.00 price target on the stock. Citigroup lifted their price target on Bruker from $29.00 to $34.00 and gave the stock a “neutral” rating in a research note on Friday, November 3rd. Zacks Investment Research cut Bruker from a “buy” rating to a “hold” rating in a research note on Friday, November 10th. Cowen reaffirmed a “hold” rating and issued a $35.00 price target on shares of Bruker in a research note on Thursday, December 21st. Finally, Morgan Stanley reaffirmed an “equal weight” rating and issued a $35.00 price target on shares of Bruker in a research note on Thursday, December 14th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and five have issued a buy rating to the stock. Bruker presently has a consensus rating of “Hold” and an average target price of $32.38.
An institutional investor recently raised its position in Bruker stock. The Manufacturers Life Insurance Company raised its holdings in Bruker Co. (NASDAQ:BRKR) by 7.1% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,003 shares of the medical research company’s stock after buying an additional 331 shares during the quarter. The Manufacturers Life Insurance Company ‘s holdings in Bruker were worth $144,000 at the end of the most recent quarter. Institutional investors and hedge funds own 65.63% of the company’s stock.
TRADEMARK VIOLATION WARNING: This piece of content was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another website, it was copied illegally and republished in violation of United States and international copyright & trademark law. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/06/bruker-brkr-set-to-announce-quarterly-earnings-on-thursday.html.
Bruker Company Profile
Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.